U.S. market Open. Closes in 5 hours 21 minutes

DXCM | DexCom, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 66.25 - 68.76
52 Week Range 62.34 - 141.99
Beta 1.38
Implied Volatility 53.12%
IV Rank 53.87%
Day's Volume 4,869,818
Average Volume 3,907,254
Shares Outstanding 390,772,000
Market Cap 26,685,819,880
Sector Healthcare
Industry Medical - Devices
IPO Date 2005-04-14
Valuation
Profitability
Growth
Health
P/E Ratio 48.09
Forward P/E Ratio 149.51
EPS 1.42
1YR Price Target 120.00
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 9,500
Country USA
Website DXCM
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem.
DXCM's peers: ALGN, BIO, BSX, TNDM, INSP, SWAV, PEN, PODD, IART, SENS, EW, INMD, MDT, ABT, ZBH, MASI, MASS, NNOX, QDEL, SYK
*Chart delayed
Analyzing fundamentals for DXCM we got that it has average fundamentals where Valuation is considered to be significantly overvalued, Profitability is very wealthy, Growth is exceptionally good and Health is strong. For more detailed analysis please see DXCM Fundamentals page.

Watching at DXCM technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on DXCM Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙